Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS – Get Free Report) crossed above its fifty day moving average during trading on Wednesday . The stock has a fifty day moving average of $1.43 and traded as high as $1.54. Corvus Pharmaceuticals shares last traded at $1.51, with a volume of 105,012 shares traded. Analyst Ratings Changes A number […]
Corvus Pharmaceuticals (NASDAQ:CRVS – Get Free Report) is set to release its earnings data after the market closes on Tuesday, November 7th. Analysts expect Corvus Pharmaceuticals to post earnings of ($0.16) per share for the quarter. Persons that wish to register for the company’s earnings conference call can do so using this link. Corvus Pharmaceuticals […]
Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS – Get Free Report) saw a significant increase in short interest in the month of September. As of September 15th, there was short interest totalling 1,820,000 shares, an increase of 32.8% from the August 31st total of 1,370,000 shares. Approximately 4.9% of the shares of the company are sold short. Based […]
Corvus Pharmaceuticals (NASDAQ:CRVS) Stock Price Crosses Below 50 Day Moving Average of $2 22 themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Corvus Pharmaceuticals (NASDAQ:CRVS) Research Coverage Started at Oppenheimer theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.